Anthrax remains a 'weapon of choice' of terrorists, experts say, but information silos, turf wars and the budget crisis still hobble the U.S. biosurveillance network.
The National Cancer Institute is retooling its research grid to give scientists access to case information from hundreds of thousands of active patients.
The coming flu season is expected to put new disease-surveillance tools through their toughest performance test ever as public health agencies gird for a return of the H1N1 virus.